Industries > Pharma > Neuromodulation Devices Report 2017-2027

Neuromodulation Devices Report 2017-2027

Revenue Forecasts for Deep Brain Stimulation, Spinal Cord, Vagus Nerve, Sacral Nerve and Gastric Electrical Applications

PUBLISHED: 01 November 2017
PAGES: 195
PRODUCT CODE: PHA0255

Clear
WOOCS 2.2.1

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector. 

In this brand new 195-page report you will receive 33 tables and 61 figures all unavailable elsewhere. 

The 195-page report provides clear detailed insight into the neuromodulation devices market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

The revenue of the neuromodulation devices market in 2016 was estimated at $3.77bn and is expected to grow at a CAGR of 11.6% in the first half of the forecast period. The spinal cord stimulation segment accounted for the largest share of the market in 2016, this segment generated $1.89bn.

Read on to discover how this definitive report can transform your own research and save you time.
The new market assessment benefits research, analysis and planning in seven main ways:
• The Neuromodulation Devices Market To 2027 – Discover That Industry’s Overall Sales Potential
• 5 Submarket Revenues To 2027 – Investigate Categories at World Level, Finding the Most Promising Therapies 
• 12 National Markets in The Americas, Europe And Asia Covered, With Forecasts To 2027 
• Activities of Established, Rising and Emerging Companies – Hear About Firms’ Products, Capabilities, Advances, Collaborations and Outlooks, Mergers and Acquisitions, Research and Development 
• Investigate Progress in The Industry, Exploring Technological, Clinical and Commercial Opportunities
• Analysis of What Stimulates and Restrains That Industry and Market – Assess Challenges, Strengths, Competition and Opportunities, Helping You Succeed.
• Discover Neuromodulation Devices Currently in Pipeline and Which Companies Are Active in Clinical Trials for Market Approvals

There you explore business intelligence with research, opinions and predictions found only in that work.

Trying our investigation now lets you discover trends, opportunities and prospects
for neuromodulation devices our report shows you data, trends, opportunities and multilevel sales forecasts. 

Report highlights

• 195 pages, 33 tables and 61 figures

• The Neuromodulation Devices Market from 2017 to 2027 

• This report also breaks down the revenue forecast for the 6 main submarkets:
• Spinal Cord Stimulation 
• Sacral Nerve Stimulation 
• Vagus Nerve Stimulation 
• Deep Brain Stimulation 
• Gastric Electric Stimulation 
• Others – trigeminal nerve stimulation, cochlear implants, transcranial magnetic stimulation, transcranial direct current stimulation and ultrasonic neuromodulation techniques.

• Analysis of key players in Neuromodulation Devices Market: 
• Medtronic 
• Boston Scientific 
• St Jude Medical (Subsidiary of Abbott Diagnostics) 
• Cyberonics (Subsidiary of LivaNova) 
• Stryker Corporation 
• Nevro Corp.
• SetPoint Medical 
• Functional Neuromodulation
• Neurotherapies Reset
• Wringless Implantable Stretchable Electronics (WISE)

Neuromodulation Devices Report 2017-2027

• Regional the Neuromodulation Devices Market forecasts from 2017-2027
• US forecast 2017-2027,
• China forecast 2017-2027
• Japan forecast 2017-2027
• India forecast 2017-2027
• Germany forecast 2017-2027
• UK forecast 2017-2027
• France forecast 2017-2027
• Italy forecast 2017-2027
• Spain forecast 2017-2027
• Brazil forecast 2017-2027
• Russia forecast 2017-2027

• Key questions answered 
• What is neuromodulation? What is the importance of neuromodulation devices, and why are they effective?
• What is the current size of the overall world neuromodulation devices market? How much will this market be worth from 2017 to 2027?
• What are the main drivers and restraints that will shape the overall neuromodulation devices market over the next ten years?
• What are the main segments within the overall neuromodulation devices market? How much will each of these segments be worth during the period 2017-2027? How will the composition of the market change during that time, and why?
• What factors will affect segments of the market over the next ten years?
• What are the largest national markets for neuromodulation devices? What is their current status and how will they develop over the next ten years? What are their sales forecasts for 2017-2027?
• How will political and regulatory factors influence regional markets?
• How will the market shares of the national markets change by 2027 and which geographical region will lead the market in 2027? 
• Who are the leading companies for neuromodulation devices and what do they do?
• What are the predictions for existing players and the prospects for new market entrants?
• What are the main trends that will affect the neuromodulation devices market between 2017 and 2027?
• What are the main strengths, weaknesses, opportunities and threats for the market?
• What are the social, technological, economic and political influences that will shape that market over the next ten years? 
• How will the global neuromodulation devices market evolve over the forecasted period of 2017-2027, including its revenues?

• Target audience
• Leading Hepatitis C companies
• Suppliers
• Contractors
• Technologists
• R&D staff
• Consultants
• Analysts
• CEO’s
• CIO’s
• COO’s
• Business development managers
• Investors
• Governments
• Agencies
• Industry organisations
• Banks

With our study you see how that market can develop and perform, benefiting your reputation for insight and authority.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6 

Download sample pages

Complete the form below to download your free sample pages for Neuromodulation Devices Report 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Neuromodulation Devices Report 2017-2027


Latest Pharma news

Visiongain Publishes Clinical Trial Supplies Market Report 2021-2031

Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.

11 October 2021

READ

Visiongain Publishes Drug Discovery Informatics Market Report 2021-2031

High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.

07 October 2021

READ

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2021-2031

Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.

06 October 2021

READ

Visiongain Publishes Meningococcal Vaccines Market Report 2021-2031

Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is expected to drive the global meningococcal vaccines market

05 October 2021

READ

Categories